April 11, 2016 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) bought Ligand Pharmaceuticals Incorporated, a stock transaction, valued at $1,001 - $15,000. The trade took place on April 11, 2016 and was disclosed on January 27, 2016 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.